Genetic testing could spur Erbitux drug sales
The drugmakers are counting on screening for the so-called K-ras gene to spur use of Erbitux in metastatic colorectal cancer.
Home » Search
Search Results
4,410 results for '\"eli lilly\"'
- Sort By
-
Date
- Any Time
- Past Day
- Past Week
- Past Month
- Past Year
-
Custom Date Range
Articles
Engine-funding battle could hurt Rolls-Royce
General Electric Co. has mounted an all-out effort to get its supporters in Congress to defy Defense Secretary Robert Gates when the House of Representatives votes on the $567 billion defense bill for fiscal 2011. GE wants Congress to keep funding its backup engine for the F-35 Joint Strike Fighter. Gates says a second engine […]
EDITORIAL: Executive pay policies, not salaries, need reform
In the wake of a recession blamed largely on Wall Street, boards need to act. But reducing executive pay shouldn’t
be their primary objective.Lilly grows Alimta’s sales by shrinking market
In 2008, Eli Lilly and Co. asked drug regulators to change the label on Alimta so Lilly could no longer promote it as a treatment
for all patients suffering from non-small-cell lung cancer, but for only about 70 percent of the patients. Since then, sales
of the drug have accelerated, growing a whopping 48 percent last year.Indianapolis startup attacks Alzheimer’s disease
AgeneBio Inc. this month landed a $300,000 investment from the Indiana Seed Fund to fund operations, bolster its intellectual
property, and begin learning how to make a drug into a once-a-day pill.Lilly spent $2.3M lobbying in first quarter
Indianapolis-based Eli Lilly and Co. spent about $2.3 million in the first quarter of 2010 lobbying the federal government
on health care reform, Medicare reimbursement and trade issues among other topics.Moody’s lowers Eli Lilly outlook to ‘negative’
Moody's Investors Service on Friday lowered its rating outlook on drugmaker Eli Lilly and Co. to "negative"
from "table" due in part to the looming expiration of patents protecting key drugs from generic competition.Eli Lilly invests in $250M Australian venture fund
The unnamed venture fund will be based in Brisbane, and will focus on biotechnology investments in Australia and southeastern
Asia.Soft Landing: Pay slipped for most execs in 2009, but cuts weren’t deep
Top executives at Indiana's public companies have largely been insulated from the economic crash. IBJ's
review of executive pay found that, although 131 of the 238 executives listed in proxy statements the past two years saw annual
compensation fall in 2009, only 10 experienced cuts of more than $1 million.Drug-spending increase highest in four years
The price increase was fueled by the debate over the health-care overhaul in Washington, D.C., Medco Health Solutions Inc. CEO David Snow said.
Lilly Endowment’s value drops to $5.3 billion
Lilly Endowment announced Monday that its assets declined 7 percent, to $5.3 billion, in 2009, as the foundation continued
to lose money on Eli Lilly and Co. stock.Lilly, others cut U.S. tax bills through transfer pricing
U.S. companies, including Eli Lilly, amassed at least $1 trillion in foreign profits not taxed in the U.S. as of the end of
last year. That cumulative total increased 70 percent over three years.Ritter’s buyer embarking on custard chain turnaround
After purchasing the Franklin-based company two years ago, TruFoods says it now is positioned to seek franchisees in an attempt
to grow the Ritter’s chain to 100 locations within five years.Lilly still waiting on once-weekly Byetta
The U.S. Food and Drug Administration last week pushed its self-declared deadline for rendering an approval decision on the
drug Bydureon to Oct. 22. The previous deadline was in March.Latest Lilly job cuts target marketing employees
Indianapolis-based drugmaker Eli Lilly and Co. is on course to cut 5,500 jobs by the end of 2011 in a bid to eliminate $1
billion in annual expenses.Lilly hopes Elanco unit becomes a cash cow
Elanco Animal Health chief Jeff Simmons predicts that consumers will opt for food made cheaper by using
Elanco’s productivity-enhancing drugs over pricier organic and locally grown products. But, as a hedge,
he has Elanco developing products to help organic farmers, too.Lilly sues to block copy of Evista osteoporosis drug
Watson Pharmaceuticals filed for FDA approval to sell a low-cost version of Eli Lilly and Co.’s osteoporosis medicine. Indianapolis-based
Lilly is seeking a court order that would block approval until three of its patents expire in 2017.SKARBECK: Diversifying not sure fix for Lilly Endowment woes
Lilly Endowment has been a substantial Lilly stockholder for 73 years, so to focus on the past decade is a mistake.